Literature DB >> 12620800

RNA recombination between cucumoviruses: possible role of predicted stem-loop structures and an internal subgenomic promoter-like motif.

Masashi Suzuki1, Tadaaki Hibi, Chikara Masuta.   

Abstract

We previously analyzed hybrids of Cucumber mosaic virus (CMV) and Tomato aspermy virus (TAV) that contained CMV RNA2 with the 3'-terminal sequence from TAV RNA2. In this article, we scrutinized the RNA3 molecules in these hybrid viruses by Northern hybridization and RT-PCR and found some recombinant CMV RNA3 molecules and various recombinant RNA4 molecules whose 3'-termini were derived from TAV RNA1 or 2. Sequence analyses revealed that most of the crossover sites for recombination were located near putative stem-loop structures and an internal subgenomic promoter-like motif. We inoculated in vitro transcripts synthesized from cDNA clones of the recombinant RNA3 onto N. benthamiana along with either CMV RNA1 and 2 or TAV RNA1 and 2. Although all of the hybrids were infectious, many sequence deletions and nucleotide substitutions were found when RNA1 and 2 from TAV were used, which suggests that fidelity of TAV replicase was lower than that of CMV replicase. The possible role of secondary structures and an internal subgenomic promoter-like motif in RNA recombination is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620800     DOI: 10.1016/s0042-6822(02)00050-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Efficient in vitro system of homologous recombination in brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Jozef J Bujarski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Characterization of a novel 5' subgenomic RNA3a derived from RNA3 of Brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Anna Urbanowicz; Aleksandra Dzianott; Marek Figlerowicz; Jozef J Bujarski
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

3.  Fixation of emerging interviral recombinants in cucumber mosaic virus populations.

Authors:  Justin S Pita; Marilyn J Roossinck
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

4.  Molecular population genetics of Cucumber mosaic virus in California: evidence for founder effects and reassortment.

Authors:  Han-Xin Lin; Luis Rubio; Ashleigh B Smythe; Bryce W Falk
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Complex recombination patterns arising during geminivirus coinfections preserve and demarcate biologically important intra-genome interaction networks.

Authors:  Darren P Martin; Pierre Lefeuvre; Arvind Varsani; Murielle Hoareau; Jean-Yves Semegni; Betty Dijoux; Claire Vincent; Bernard Reynaud; Jean-Michel Lett
Journal:  PLoS Pathog       Date:  2011-09-15       Impact factor: 6.823

6.  Complete Genome Sequences of Three Tomato Aspermy Virus Isolates in Japan.

Authors:  Sota Inoue; Misato Tamura; Masashi Ugaki; Masashi Suzuki
Journal:  Genome Announc       Date:  2018-05-31

7.  Recombination of 5' subgenomic RNA3a with genomic RNA3 of Brome mosaic bromovirus in vitro and in vivo.

Authors:  Joanna Sztuba-Solińska; Aleksandra Dzianott; Jozef J Bujarski
Journal:  Virology       Date:  2010-11-26       Impact factor: 3.616

Review 8.  Subgenomic messenger RNAs: mastering regulation of (+)-strand RNA virus life cycle.

Authors:  Joanna Sztuba-Solińska; Victor Stollar; Jozef J Bujarski
Journal:  Virology       Date:  2011-03-05       Impact factor: 3.616

9.  The cucumovirus 2b gene drives selection of inter-viral recombinants affecting the crossover site, the acceptor RNA and the rate of selection.

Authors:  Bu-Jun Shi; Robert H Symons; Peter Palukaitis
Journal:  Nucleic Acids Res       Date:  2007-12-17       Impact factor: 16.971

10.  Mutations in the coat protein-binding cis-acting RNA motifs debilitate RNA recombination of Brome mosaic virus.

Authors:  Joanna Sztuba-Solińska; Sean W Fanning; James R Horn; Jozef J Bujarski
Journal:  Virus Res       Date:  2012-10-16       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.